Duke Researchers Receive Grant to Roll Out Next-Generation Coronavirus Vaccine
Pandemic Response Shows Path For Improved Health Care in the Future
In many ways, the COVID-19 pandemic forced positive changes in how medicine is practiced in communities and at academic medical centers, with Family Medicine departments working at the front lines
Research Finds Masks Can Prevent COVID-19 Transmission in Schools
The widespread use of masks in schools can effectively prevent COVID-19 transmission and provide a safe learning environment, two Duke scholars said Wednesday.
Duke-led team identifies new coronavirus threat to humans
Researchers have discovered a new coronavirus, found in a child with pneumonia in Malaysia in 2018, that appears to have jumped from dog to human.
Newly Identified Antibody Can Be Targeted by HIV Vaccines
A newly identified group of antibodies that binds to a coating of sugars on the outer shell of HIV is effective in neutralizing the virus and points to a novel vaccine approach that could also pote
Duke Health sends supplies to India to assist with Covid-19 Crisis
Hundreds of boxes of protective gear and equipment are now available to health care workers in New Delhi thanks to the quick, coordinated response of Duke Health faculty and staff.
New vaccine blocks COVID-19 and variants, plus other Coronaviruses
A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections -- including SARS-CoV-2
Duke-led team finds why women may be better equipped to Fight COVID
When it comes to COVID-19, women seem to be the stronger sex, suffering severe disease at about half the rate as men, but the reason for this has been elusive.
Duke enrolls first-in-nation children for Pfizer-BioNTech U.S. clinical study trial in children under 12
Twin 9-year-old girls at Duke Health became the first in the United States to participate in Pfizer and BioNTech Phase 1 study to evaluate safety, tolerability and immunogenicity of the Pfizer-BioN